Achyutharao
Achyutharao Sidduri, Livingston, NJ US
Patent application number | Description | Published |
---|---|---|
20090054466 | Leukotriene B4 Inhibitors - Provided herein are compounds of the formula (I): | 02-26-2009 |
20090253684 | LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula (I): | 10-08-2009 |
20100041713 | SUBSTITUTED AMINOTETRALINES - The invention is concerned with the compounds of formula I: | 02-18-2010 |
20100137250 | NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula I: | 06-03-2010 |
20100240678 | LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula (I): | 09-23-2010 |
20130059834 | PYRROLOPYRAZINE KINASE INHIBITORS - The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, | 03-07-2013 |
20130079383 | Lipid Compounds Targeting VLA-4 - The invention relates to the compounds of formula I: | 03-28-2013 |
20130116322 | ALKENYL NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula (I): | 05-09-2013 |
20150031715 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING VLA-4 - The invention relates to compounds of formula I: wherein R1, R2, and n are defined in the detailed description and claims. In particular, the present invention relates to the compounds of formula I for use in the manufacture and delivery of conjugated moieties such as small molecules, peptides, nucleic acids, fluorescent moieties, and polymers which are linked to VLA-4 integrin antagonists to target cells expressing VLA-4. | 01-29-2015 |
20150038523 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3 - The invention relates to compounds of formula (I): wherein R | 02-05-2015 |
Achyutharao Sidduri, West Orange, NJ US
Patent application number | Description | Published |
---|---|---|
20130150407 | PIPERIDINYL NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula (I): | 06-13-2013 |
20130197059 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1 - The invention relates to compounds of formula I: | 08-01-2013 |
20130197205 | CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY - The invention relates to the chitosan polymer derivatives of formula I: | 08-01-2013 |
20130225588 | SUBSTITUTED NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula (I): | 08-29-2013 |
20150065534 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1 - The invention relates to compounds of formula (I), wherein R1, R2, and n are defined in the detailed description and claims. In particular, the present invention relates to the compounds of formula I for use in the manufacture and delivery of conjugated moieties such as small molecules, peptides, nucleic acids, fluorescent moieties, and polymers which are linked to LFA-1 integrin antagonists to target cells expressing LFA-1. | 03-05-2015 |
Achyutharao Sidduri, Newark, NJ US
Patent application number | Description | Published |
---|---|---|
20140194431 | PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE - The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, | 07-10-2014 |
20140194432 | NAPHTHYRIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE - The present invention relates to a compound having the general formula (V), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, | 07-10-2014 |